Scott Britz-Cunningham to Fluorodeoxyglucose F18
This is a "connection" page, showing publications Scott Britz-Cunningham has written about Fluorodeoxyglucose F18.
Connection Strength
0.821
-
Gerbaudo VH, Britz-Cunningham S. Primary lesions were more 18F-FDG avid in patients with distant spread than in those without extensive disease. Mol Imaging Biol. 2009 Nov-Dec; 11(6):487; author reply 488.
Score: 0.312
-
Britz-Cunningham SH, Millstine JW, Gerbaudo VH. Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum. Clin Nucl Med. 2008 Oct; 33(10):681-7.
Score: 0.289
-
Halpern BS, Britz-Cunningham SH, Kim CK. Intense focal F-18 FDG uptake in vocal cord associated with injection of calcium hydroxylapatite microspheres. Clin Nucl Med. 2011 Nov; 36(11):e175-7.
Score: 0.089
-
Shyn PB, Mortele KJ, Britz-Cunningham SH, Friedman S, Odze RD, Burakoff R, Goldberg JE, Erturk M, Silverman SG. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease. J Nucl Med. 2010 Dec; 51(12):1841-8.
Score: 0.084
-
Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med. 2002 Sep; 43(9):1144-9.
Score: 0.047